T cells in ANCA-associated vasculitis: What can we learn from lesional versus circulating T cells?

Arthritis Research and Therapy

Volumn 12, Issue 1, 2010, Pages

  Wilde, Benjamin ^a,b   Thewissen, Marielle ^a   Damoiseaux, Jan ^a   van Paassen, Pieter ^a   Witzke, Oliver ^b   Tervaert, Jan Willem C ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

DENDRITIC CELL; EFFECTOR CELL; GRANULOMA; IMMUNE RESPONSE; LYMPHOCYTE SUBPOPULATION; MEMORY T LYMPHOCYTE; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; TISSUE INJURY; VASCULITIS; ANCA ASSOCIATED VASCULITIS; ANIMAL; BLOOD; HUMAN; IMMUNOLOGY; PATHOLOGY;

ANIMALS; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; HUMANS; T-LYMPHOCYTES;

EID: 77955504544     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2923     Document Type: Review

References (87)

1. Cohen Tervaert JW, Limburg PC, Elema JD, Huitema MG, The TH, Kallenberg CGM, Horst G. Detection of autoantibodies against myeloid lysosomalenzymes - a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis. Am J Med 1991, 91:59-66.
2. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico RA, Rees AJ, Van Es LA, Waldherr R, Wiik A. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37:187-192.
3. Tipping PG, Holdsworth SR. T cells in crescentic glomerulonephritis. J Am Soc Nephrol 2006, 17:1253-1263.
4. Popa ER, Stegeman CA, Bos NA, Kallenberg CGM, Tervaert JWC. Differential B- and T-cell activation in Wegener's granulomatosis. J Allergy Clin Immunol 1999, 103:885-894.
5. Stegeman CA, Tervaert JWC, Huitema MG, Kallenberg CGM. Serum markers of T-cell activation in relapses of Wegeners granulomatosis. Clin Exp Immunol 1993, 91:415-420. 1554716, 8443965.
6. Schmitt WH, Heesen C, Csernok E, Rautmann A, Gross WL. Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity. Arthritis Rheum 1992, 35:1088-1096.
7. Yang JJ, Bautz DJ, Lionaki S, Hogan SL, Chin H, Tisch RM, Schmitz JL, Pressler BM, Jennette JC, Falk RJ, Preston GA. ANCA patients have T cells responsive to complementary PR-3 antigen. Kidney Int 2008, 74:1159-1169. 2754720, 18596726.
8. Abdulahad WH, Stegeman CA, Limburg PC, Kallenberg CG. Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. Arthritis Rheum 2008, 58:2196-2205.
9. Ruth A-J, Kitching AR, Kwan RYQ, Odobasic D, Ooi JDK, Timoshanko JR, Hickey MJ, Holdsworth SR. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis. J Am Soc Nephrol 2006, 17:1940-1949.
10. Schmitt WH, Hagen EC, Neumann I, Nowack R, Flores-Suarez LF, Woude FJ. Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients. Kidney Int 2004, 65:1440-1448.
11. Marinaki S, Neumann I, Kalsch AI, Grimminger P, Breedijk A, Birck R, Schmitt W, Waldherr R, Yard BA, Woude FJ. Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis. Clin Exp Immunol 2005, 140:181-191. 1809336, 15762890.
12. Wilde B, Dolff S, Cai X, Specker C, Becker J, Tötsch M, Costabel U, Dürig J, Kribben A, Tervaert JW, Schmid KW, Witzke O. CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis. Nephrol Dial Transplant 2009, 24:161-171.
13. Abdulahad WH, Geld YM, Stegeman CA, Kallenberg CG. Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis. Kidney Int 2006, 70:938-947.
14. Sakaguchi S, Setoguchi R, Yagi H, Nomura T. Naturally arising Foxp3- expressing CD25+CD4+ regulatory T cells in self-tolerance and autoimmune disease. Curr Top Microbiol Immunol 2006, 305:51-66.
15. Abdulahad WH, Stegeman CA, Geld YM, Doornbos-van der Meer B, Limburg PC, Kallenberg CG. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission. Arthritis Rheum 2007, 56:2080-2091.
16. Michel L, Berthelot L, Pettre S, Wiertlewski S, Lefrere F, Braudeau C, Brouard S, Soulillou JP, Laplaud DA. Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysis. J Clin Invest 2008, 118:3411-3419. 2525698, 18769633.
17. Tran DQ, Ramsey H, Shevach EM. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-{beta} dependent but does not confer a regulatory phenotype. Blood 2007, 110:2983-2990. 2018674, 17644734.
18. Tran DQ, Shevach EM. Response: anti human FOXP3 mAb PCH101 stains activated human naive T cells nonspecifically. Blood 2008, 111:464-466.
19. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, Höpner S, Centonze D, Bernardi G, Dell'Acqua ML, Rossini PM, Battistini L, Rötzschke O, Falk K. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007, 110:1225-1232.
20. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, Fazekas de St Groth B, Clayberger C, Soper DM, Ziegler SF, Bluestone JA. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006, 203:1701-1711. 2118339, 16818678.
21. De Rosa V, Procaccini C, Calì G, Pirozzi G, Fontana S, Zappacosta S, La Cava A, Matarese G. A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007, 26:241-255.
22. Kümpers P, Horn R, Brabant G, Woywodt A, Schiffer M, Haller H, Haubitz M. Serum leptin and ghrelin correlate with disease activity in ANCA-associated vasculitis. Rheumatology 2008, 47:484-487.
23. Thewissen M, Cohen Tervaert JW. Leptin and ANCA-associated vasculitis: a healthy link?. Rheumatology 2008, 47:387-389.
24. Marinaki S, Kalsch AI, Grimminger P, Breedijk A, Birck R, Schmitt WH, Weiss C, Woude FJ, Yard BA. Persistent T-cell activation and clinical correlations in patients with ANCA-associated systemic vasculitis. Nephrol Dial Transplant 2006, 21:1825-1832.
25. Abdulahad WH, Kallenberg C, Limburg P, Stegeman C. Urinary CD4 effector memory T-cells as a measure of renal disease activity in ANCA-associated vasculitis. Arthritis Rheum 2008, 58:S851-S851.
26. Stockinger B, Bourgeois C, Kassiotis G. CD4(+) memory T cells: functional differentiation and homeostasis. Immunol Rev 2006, 211:39-48.
27. Kreijveld E, Koenen HJPM, van Cranenbroek B, van Rijssen E, Joosten I, Hilbrands LB. Immunological monitoring of renal transplant recipients to predict acute allograft rejection following the discontinuation of tacrolimus. PLoS ONE 2008, 3:e2711. 2442873, 18628993.
28. Lamprecht P, Moosig F, Csernok E, Seitzer U, Schnabel A, Mueller A, Gross WL. CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosis. Thorax 2001, 56:751-757. 1745938, 11562512.
29. Moosig F, Csernok E, Wang G, Gross WL. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells. Clin Exp Immunol 1998, 114:113-118. 1905085, 9764612.
30. Steiner K, Moosig F, Csernok E, Selleng K, Gross WL, Fleischer B, Broker BM. Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosis. Clin Exp Immunol 2001, 126:143-150. 1906160, 11678911.
31. Komocsi A, Lamprecht P, Csernok E, Mueller A, Holl-Ulrich K, Seitzer U, Moosig F, Schnabel A, Gross WL. Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis. Am J Pathol 2002, 160:1717-1724. 1850873, 12000723.
32. Capraru D, Müller A, Csernok E, Gross WL, Holl-Ulrich K, Northfield J, Klenerman P, Herlyn K, Holle J, Gottschlich S, Voswinkel J, Spies T, Fagin U, Jabs WJ, Lamprecht P. Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener's granulomatosis. Clin Immunol 2008, 127:144-150.
33. Vogt S, Iking-Konert C, Hug F, Andrassy K, Hansch GM. Shortening of telomeres: Evidence for replicative senescence of T cells derived from patients with Wegener's granulomatosis. Kidney Int 2003, 63:2144-2151.
34. Thewissen M, Somers V, Hellings N, Fraussen J, Damoiseaux J, Stinissen P. CD4+CD28null T cells in autoimmune disease: pathogenic features and decreased susceptibility to immunoregulation. J Immunol 2007, 179:6514-6523.
35. Berg PJ, van Leeuwen EM, ten Berge IJ, van Lier R. Cytotoxic human CD4+ T cells. Curr Opin Immunol 2008, 20:339-343.
36. Vallejo AN. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev 2005, 205:158-169.
37. Holling TM, Schooten E, Elsen PJ. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men. Hum Immunol 2004, 65:282-290.
38. Pandiyan P, Gartner D, Soezeri O, Radbruch A, Schulze-Osthoff K, Brunner-Weinzierl MC. CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3 kinase function. J Exp Med 2004, 199:831-842. 2212725, 15007096.
39. Spriewald BM, Witzke O, Wassmuth R, Wenzel RR, Arnold ML, Philipp T, Kalden JR. Distinct tumour necrosis factor alpha, interferon gamma, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosis. Ann Rheum Dis 2005, 64:457-461. 1755422, 15708894.
40. Zhou YH, Huang DR, Paris PL, Sauter CS, Prock KA, Hoffman GS. An analysis of CTLA-4 and proinflammatory cytokine genes in Wegener's granulomatosis. Arthritis Rheum 2004, 50:2645-2650.
41. Huang D, Giscombe R, Zhou YH, Lefvert K. Polymorphisms in CTLA-4 but not tumor necrosis factor-alpha or interleukin 1 beta genes are associated with Wegener's granulomatosis. J Rheumatol 2000, 27:397-401.
42. Slot MC, Sokolowska MG, Savelkouls KG, Janssen R, Damoiseaux J, Tervaert JWC. Immunoregulatory gene polymorphisms are associated with ANCA-related vasculitis. Clin Immunol 2008, 128:39-45.
43. Huang DR, Giscombe R, Zhou YH, Pirskanen R, Lefvert AK. Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis. J Neuroimmunol 2000, 105:69-77.
44. Schmitt WH, Csernok E, Kobayashi S, Klinkenborg A, Reinhold-Keller E, Gross WL. Churg-Strauss syndrome - Serum markers of lymphocyte activation and endothelial damage. Arthritis Rheum 1998, 41:445-452.
45. Nassonov EL, Samsonov MY, Tilz GP, Beketova TV, Semenkova EN, Baranov A, Wachter H, Fuchs D. Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis. J Rheumatol 1997, 24:666-670.
46. Kobold ACM, Kallenberg CGM, Tervaert JWC. Monocyte activation in patients with Wegener's granulomatosis. Ann Rheum Dis 1999, 58:237-245. 1752857, 10364903.
47. Sanders JSF, Huitma MG, Kallenberg CGM, Stegeman CA. Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse. Ann Rheum Dis 2006, 65:1484-1489. 1798350, 16504995.
48. Balding CEJ, Howie AJ, Drake-Lee AB, Savage COS. Th2 dominance in nasal mucosa in patients with Wegener's granulomatosis. Clin Exp Immunol 2001, 125:332-339. 1906130, 11529927.
49. Csernok E, Trabandt A, Muller A, Wang GCC, Moosig F, Paulsen J, Schnabel A, Gross WL. Cytokine profiles in Wegener's granulomatosis - Predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheum 1999, 42:742-750.
50. Kiene A, Csernok E, Mulller A, Metzler C, Trabandt A, Gross WL. Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome. Arthritis Rheum 2001, 44:469-473.
51. Fraticelli P, Sironi M, Bianchi G, D'Ambrosio D, Albanesi C, Stoppacciaro A, Chieppa M, Allavena P, Ruco L, Girolomoni G, Sinigaglia F, Vecchi A, Mantovani A. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest 2001, 107:1173-1181. 209276, 11342581.
52. Schonermarck U, Csernok E, Trabandt A, Hansen H, Gross WL. Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides. Clin Exp Rheumatol 2000, 18:457-463.
53. Csernok E, Muller A, Gross WL. Immunopathology of ANCA-associated vasculitis. Intern Med 1999, 38:759-765.
54. Lamprecht P, Bruhl H, Erdmann A, Holl-Ulrich K, Csernok E, Seitzer U, Mack M, Feller AC, Reinhold-Keller E, Gross WL, Muller A. Differences in CCR5 expression on peripheral blood CD4+CD28- T-cells and in granulomatous lesions between localized and generalized Wegener's granulomatosis. Clin Immunol 2003, 108:1-7.
55. Lamprecht P, Erdmann A, Mueller A, Csernok E, Reinhold-Keller E, Holl-Ulrich K, Feller AC, Bruehl H, Gross WL. Heterogeneity of CD4 and CD8+ memory T cells in localized and generalized Wegener's granulomatosis. Arthritis Res Ther 2003, 5:R25-31. 154430, 12716450.
56. Muller A, Trabandt A, Gloeckner-Hofmann K, Seitzer U, Csernok E, Schonermarck U, Feller AC, Gross WL. Localized Wegener's granulomatosis: predominance of CD26 and IFN-gamma expression. J Pathol 2000, 192:113-120.
57. Bettelli E, Oukka M, Kuchroo VK. TH-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007, 8:345-350.
58. Saito H, Tsurikisawa N, Tsuburai T, Oshikata C, Akiyama K. Cytokine production profile of CD4+ T cells from patients with active Churg-Strauss syndrome tends toward Th17. Int Arch Allergy Immunol 2009, 149:61-65.
59. Ordonez L, Bernard I, L'Faqihi-Olive F, Cohen Tervaert JW, Damoiseaux J, Saoudi A. CD45RC isoform expression identifies functionally distinct T cell subsets differentially distributed between healthy individuals and AAV patients. PLoS ONE 2009, 4:e5287. 2668071, 19381293.
60. Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M, Mineau F, Pelletier JP. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 1998, 160:3513-3521.
61. Voswinkel J, Muller A, Lamprecht P. Is PR3-ANCA formation initiated in Wegener's granulomatosis lesions? Granulomas as potential lymphoid tissue maintaining autoantibody production. Ann N Y Acad Sci 2005, 1051:12-19.
62. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004, 22:745-763.
63. Co DO, Hogan LH, Il-Kim S, Sandor M. T cell contributions to the different phases of granuloma formation. Immunol Lett 2004, 92:135-142.
64. Shiao SL, Kirkiles-Smith NC, Shepherd BR, McNiff JM, Carr EJ, Pober JS. Human effector memory CD4+ T cells directly recognize allogeneic endothelial cells in vitro and in vivo. J Immunol 2007, 179:4397-4404.
65. Mestas J, Crampton SP, Hori T, Hughes CCW. Endothelial cell co-stimulation through OX40 augments and prolongs T cell cytokine synthesis by stabilization of cytokine mRNA. Int Immunol 2005, 17:737-747.
66. Imura A, Hori T, Imada K, Ishikawa T, Tanaka Y, Maeda M, Imamura S, Uchiyama T. The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J Exp Med 1996, 183:2185-2195. 2192546, 8642328.
67. Noronha IL, Kruger C, Andrassy K, Ritz E, Waldherr R. In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int 1993, 43:682-692.
68. Yamaoka J, Kabashima K, Kawanishi M, Toda K-I, Miyachi Y. Cytotoxicity of IFN-[gamma] and TNF-[alpha] for vascular endothelial cell is mediated by nitric oxide. Biochem Biophys Res Commun 2002, 291:780-786.
69. Bratt J, Palmblad J. Cytokine-induced neutrophil-mediated injury of human endothelial cells. J Immunol 1997, 159:912-918.
70. Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006, 6:205-217.
71. Mueller A, Holl-Ulrich K, Lamprecht P, Gross WL. Germinal centre-like structures in Wegener's granuloma: the morphological basis for autoimmunity?. Rheumatology 2008, 47:1111-1113.
72. Csernok E, Ai M, Gross WL, Wicklein D, Petersen A, Lindner B, Lamprecht P, Holle JU, Hellmich B. Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway. Blood 2006, 107:4440-4448.
73. Voswinkel J, Mueller A, Kraemer JA, Lamprecht P, Herlyn K, Holl-Ulrich K, Feller AC, Pitann S, Gause A, Gross WL. B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions. Ann Rheum Dis 2006, 65:859-864. 1798221, 16291812.
74. Segerer S, Heller F, Lindenmeyer MT, Schmid H, Cohen CD, Draganovici D, Mandelbaum J, Nelson PJ, Gröne HJ, Gröne EF, Figel AM, Nössner E, Schlöndorff D. Compartment specific expression of dendritic cell markers in human glomerulonephritis. Kidney Int 2008, 74:37-46.
75. Wilde B, van Paassen P, Damoiseaux J, Heerings-Rewinkel P, van Rie H, Witzke O, Tervaert JW. Dendritic cells in renal biopsies of patients with ANCA-associated vasculitis. Nephrol Dial Transplant 2009, 24:2151-2156.
76. Steinmetz O, Velden J, Kneissler U, Marx M, Klein A, Helmchen U. Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis. Kidney Int 2008, 74:448-457.
77. Scholz J, Lukacs-Kornek V, Engel DR, Specht S, Kiss E, Eitner F, Floege J, Groene HJ, Kurts C. Kidney dendritic cells stimulate IL-10 production in nephrotoxic nephritis and attenuate disease. J Am Soc Nephrol 2008, 19:527-537. 2391058, 18235094.
78. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol 2002, 23:445-449.
79. Trzonkowski P, Szarynska M, Mysliwska J, Mysliwski A. Ex vivo expansion of CD4(+)CD25(+) T regulatory cells for immunosuppressive therapy. Cytometry A 2009, 75:175-188.
80. Koenen HJPM, Smeets RL, Vink PM, van Rijssen E, Boots AMH, Joosten I. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 2008, 112:2340-2352.
81. Genovese MC, Becker JC, Schiff M, Luggen M, Sherrer Y, Kremer J, Birbara C, Box J, Natarajan K, Nuamah I, Li T, Aranda R, Hagerty DT, Dougados M. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor {alpha} inhibition. N Engl J Med 2005, 353:1114-1123.
82. Vincenti F, Kirkman R, Light S, Bumgardner G, Pescovitz M, Halloran P, Neylan J, Wilkinson A, Ekberg H, Gaston R, Backman L, Burdick J. Interleukin-2- receptor blockade with daclizumab to prevent acute rejection in renal transplantation. N Engl J Med 1998, 338:161-165.
83. Nieuwhof CMG, Damoiseaux J, Tervaert JWC. Successful treatment of cerebral vasculitis in an HIV-positive patient with anti-CD25 treatment. Ann Rheum Dis 2006, 65:1677-1678. 1798457, 17105864.
84. Bielekova B, Richert N, Howard T, Blevins G, Markovic-Plese S, McCartin J, Wurfel J, Ohayon J, Waidmann TA, McFarland HF, Martin R. Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta. Proc Natl Acad Sci USA 2004, 101:8705-8708. 423259, 15161974.
85. Hoyer KK, Dooms H, Barron L, Abbas AK. Interleukin-2 in the development and control of inflammatory disease. Immunol Rev 2008, 226:19-28.
86. Stuve O, Gold R, Chan A, Mix E, Zettl U, Kieseier BC. alpha 4-Integrin antagonism with natalizumab effects and adverse effects. J Neurol 2008, 255:58-65.
87. van Paassen P, Tervaert JWC, Heeringa P. Mechanisms of vasculitis: how pauci-immune is ANCA-associated renal vasculitis?. Nephron Exp Nephrol 2007, 105:e10-16.